The candidate vaccine’s next steps will be going through the FDA’s Biologics License Application process.
|Articles|March 26, 2007
Framework for successful product launches released
A new paper released by NACDS and prepared by PricewaterhouseCoopers has identified the following four steps for successful new product launches.
Advertisement
A new paper released by NACDS and prepared by PricewaterhouseCoopers has identified the following four steps for successful new product launches:
- Understand and eliminate preconceived notions of each trading partner and establish a joint definition of launch success beyond just sales/volume targets;
- establish detailed milestones and success criteria and assign specific responsibility and accountability for each element;
- provide transparency to potential launch issues and develop contingency planning in advance for likely scenarios to avoid overreacting to expected event;
- devote time to post-launch analysis. For more information, visit
Advertisement
Related to this article
The Milken Institute released survey results alongside new data regarding the need for pharmacists in extending effective GLP-1 care.
Through the ACCESS program, Mark Ey, RPh, notes that pharmacies can now start billing for a variety of services they’ve already been providing.
The medication significantly increased risk of pregnancy loss when compared with macrolide antibiotics, amoxicillin, and topical clindamycin for acne.
In part 3, Rebold explores improving the ART formulary protocol through introducing pharmacist-led transition-of-care services.
Our hosts explore why ketone monitoring matters, what pharmacists should know about Libre Duo, and how patient education can support proactive care management.
Mark Ey, RPh, details the patient-focused factors of the ACCESS to Pharmacy Care Program and the ways in which valued care translates to reimbursement.
A new option for adults who have experienced stroke will now be available to further reduce future risk.
Advertisement
Advertisement
Trending on Drug Topics
1
FDA Adds NAION Eye Risk Warning to All GLP-1 Labels
2
The Pharmacy Model Creating New Billing Pathways, Improved Recognition
3
Doxycycline Use Associated with Higher Risk of Pregnancy Loss
4
Pharmacist-Led Transitions of Care Could Be Crucial in HIV Treatment
5